Skip to main content

Advertisement

Log in

Equivalency of RT-PCR and immunohistochemistry: fact or factoid

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani T, Zografos G, Gogas H et al Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Co-operative Oncology Group Trial. Breast Cancer Res Treat

  2. Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML et al (2008) Estrogen-and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 20(26):2473–2481. doi:10.1200/JCO.2007.13.6424

    Article  Google Scholar 

  3. Bianchini G, Zambetti M, Pustzai L, Carcangiu ML, Valagussa P, Gianni L (2007) Use of estrogen receptor (ER) expression by quantitative RT-PCR to identify an ER-negative subgroup by IHC who might benefit from hormonal therapy. 2007 Breast Cancer Symposium; Abstr 106

  4. Gong Y, Yan K, Lin F, Anderson K, Sotiriou C, Andre F et al (2007) Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol 8:203–211. doi:10.1016/S1470-2045(07)70042-6

    Article  PubMed  CAS  Google Scholar 

  5. Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC et al (2004) Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 164:35–42

    PubMed  CAS  Google Scholar 

  6. Abramovitz M, Ordanic-Kodani M, Wang Y, Li Z, Catzavelos C, Bouzyk M et al (2008) Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. Biotechniques 44:417–423. doi:10.2144/000112703

    Article  PubMed  CAS  Google Scholar 

  7. Suzuki T, Higgins PJ, Crawford DR (2000) Control selection for RNA quantitation. Biotechniques 29:332–337

    PubMed  CAS  Google Scholar 

  8. Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L (2005) Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle 4:1149–1152

    PubMed  CAS  Google Scholar 

  9. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145. doi:10.1200/JCO.2006.09.2775

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sunil Badve.

Additional information

This is a commentary to doi:10.1007/s10549-008-0144-9.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Badve, S. Equivalency of RT-PCR and immunohistochemistry: fact or factoid. Breast Cancer Res Treat 116, 145–147 (2009). https://doi.org/10.1007/s10549-008-0176-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-008-0176-1

Keywords

Navigation